|
|
|
Insider
Information: |
Evans Daron |
Relationship: |
|
City: |
Berkeley |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
269,718 |
|
Indirect Shares
|
100,269 |
|
|
Direct
Value |
$572,880 |
|
|
Indirect Value
|
$336,266 |
|
|
Total
Shares |
369,987 |
|
|
Total
Value |
$909,146 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
8
|
0
|
Stock
price went up :
|
6
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
Percentage
Gain/Loss : |
73.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Capricor Therapeutics |
CAPR |
Chief Financial Officer |
2009-07-07 |
14,152 |
2009-07-07 |
9,600 |
Premium* |
|
Nephros Inc |
NEPH |
CEO Specialty Renal Pr... |
2021-05-24 |
134,215 |
2021-05-27 |
8,669 |
Premium* |
|
Rezolute, Inc |
RZLT |
|
2024-06-14 |
121,351 |
2024-06-14 |
82,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NEPH |
Nephros Inc |
Director |
|
2013-11-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,500 |
|
- |
|
RZLT |
Rezolute, Inc |
CFO |
|
2024-01-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,000 |
|
% |
|
RZLT |
Rezolute, Inc |
CFO |
|
2024-01-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,000 |
|
% |
|
CAPR |
Capricor Therapeutics |
Chief Financial Officer |
|
2008-04-14 |
4 |
B |
$4.50 |
$900 |
D/D |
200 |
200 |
2.66 |
- |
|
CAPR |
Capricor Therapeutics |
Chief Financial Officer |
|
2008-04-14 |
4 |
B |
$4.50 |
$2,740 |
I/I |
600 |
200 |
1.91 |
- |
|
CAPR |
Capricor Therapeutics |
Chief Financial Officer |
|
2008-12-11 |
4 |
B |
$0.81 |
$2,430 |
D/D |
3,000 |
3,200 |
2.66 |
- |
|
CAPR |
Capricor Therapeutics |
Chief Financial Officer |
|
2008-12-11 |
4 |
B |
$0.54 |
$440 |
I/I |
814 |
1,014 |
1.91 |
- |
|
CAPR |
Capricor Therapeutics |
Chief Financial Officer |
|
2008-12-12 |
4 |
B |
$1.25 |
$1,250 |
D/D |
1,000 |
4,200 |
2.66 |
- |
|
CAPR |
Capricor Therapeutics |
Chief Financial Officer |
|
2008-12-12 |
4 |
B |
$0.70 |
$2,230 |
I/I |
3,186 |
4,200 |
1.91 |
- |
|
CAPR |
Capricor Therapeutics |
Chief Financial Officer |
|
2009-03-11 |
4 |
B |
$0.77 |
$4,620 |
I/I |
6,000 |
10,200 |
1.91 |
- |
|
CAPR |
Capricor Therapeutics |
Chief Financial Officer |
|
2009-03-13 |
4 |
B |
$0.75 |
$3,750 |
D/D |
5,000 |
9,200 |
2.66 |
- |
|
CAPR |
Capricor Therapeutics |
Chief Financial Officer |
|
2009-07-07 |
4 |
B |
$0.00 |
$0 |
D/D |
3,952 |
14,152 |
2.66 |
- |
|
NEPH |
Nephros Inc |
Director |
|
2014-03-21 |
4 |
A |
$0.30 |
$645 |
D/D |
2,151 |
9,651 |
0 |
- |
|
NEPH |
Nephros Inc |
Director |
|
2014-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
43,194 |
52,845 |
0 |
- |
|
NEPH |
Nephros Inc |
Director |
|
2014-12-18 |
4 |
A |
$0.60 |
$12,743 |
D/D |
21,239 |
74,084 |
0 |
- |
|
NEPH |
Nephros Inc |
President and CEO |
|
2015-08-19 |
4 |
B |
$0.50 |
$12,250 |
D/D |
24,500 |
98,584 |
2.81 |
- |
|
NEPH |
Nephros Inc |
President and CEO |
|
2015-08-20 |
4 |
B |
$0.56 |
$15,120 |
D/D |
27,000 |
125,584 |
2.81 |
- |
|
NEPH |
Nephros Inc |
President and CEO |
|
2015-08-27 |
4 |
B |
$0.56 |
$10,738 |
D/D |
19,175 |
144,759 |
2.81 |
- |
|
NEPH |
Nephros Inc |
President and CEO |
|
2015-08-28 |
4 |
B |
$0.58 |
$8,900 |
D/D |
15,000 |
159,759 |
2.81 |
- |
|
NEPH |
Nephros Inc |
President and CEO |
|
2015-08-31 |
4 |
B |
$0.57 |
$5,700 |
D/D |
10,000 |
169,759 |
2.81 |
- |
|
NEPH |
Nephros Inc |
President and CEO |
|
2015-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
70,610 |
240,369 |
0 |
- |
|
NEPH |
Nephros Inc |
President and CEO |
|
2015-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
42,840 |
283,209 |
0 |
- |
|
NEPH |
Nephros Inc |
President and CEO |
|
2016-11-30 |
4 |
B |
$0.29 |
$270 |
D/D |
931 |
284,140 |
2.73 |
- |
|
NEPH |
Nephros Inc |
President and CEO |
|
2016-12-01 |
4 |
B |
$0.32 |
$13,016 |
D/D |
40,599 |
324,739 |
2.81 |
- |
|
NEPH |
Nephros Inc |
President and CEO |
|
2016-12-05 |
4 |
B |
$0.34 |
$3,610 |
D/D |
10,620 |
335,359 |
2.73 |
- |
|
59 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|